These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: In vitro brodimoprim activity on bacterial strains. Author: Benoit-Lemercier C, Bergogne-Bérézin E, Joly-Guillou ML. Journal: J Chemother; 1993 Dec; 5(6):435-43. PubMed ID: 8195835. Abstract: The antibacterial activity of brodimoprim (BDP) was compared to that of trimethoprim (TMP) and to 4 other antibiotics (3 beta-lactams and one macrolide). The 237 tested strains were selected predominantly among bacteria isolated from respiratory tract infections: 133 Gram-negative bacilli and 98 Gram-positive cocci. The study included: determination of minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) of all antibiotics of the study for all isolates; kinetics of bactericidal activities for selected susceptible strains; correlation between MICs and inhibition zones (standard agar diffusion technique) of BDP (regression line). The results of the study showed: [1] no significant difference between in vitro activities of BDP and TMP against all tested strains; [2] low MICs of both drugs for Haemophilus influenzae, Legionella pneumophila, Staphylococcus aureus (methi-S and methi-R), Streptococcus pneumoniae (peni-S), streptococci and enterococci; [3] kinetics of bactericidal activities indicating 4 log decrease of inoculum size with BDP for Staph. aureus, S. pneumoniae, H. influenzae, within 7 hours; [4] correlation was established between inhibition zones and MICs of BDP, with a coefficient of correlation r = 0.88 for 182 strains. In conclusion, BDP exhibited in vitro antibacterial and bactericidal activities at least equal to that of reference drugs against most respiratory pathogens; BDP was superior to comparators against methi-R staphylococci and enterococci.[Abstract] [Full Text] [Related] [New Search]